Home › Funds › Biondo Investment Advisors, LLC › REGN

Biondo Investment Advisors, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Biondo Investment Advisors, LLC reported holding 10,983 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 0.99% of its reported portfolio and ranking #34 among its reported holdings. Biondo Investment Advisors, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.98K sh
Reported value held$8.33M
Portfolio Weight0.99%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Biondo Investment Advisors, LLC's REGN position evolved

Biondo Investment Advisors, LLC first disclosed a stake in REGN in Q3 2023 at 855 shares (US$704K). The position peaked in Q1 2026 at 10,892 shares, worth US$8.4M. Across 13 filings, Biondo Investment Advisors, LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 10,983 shares valued at US$8.3M — a reduction of -227 shares quarter over quarter.. Notable position changes include a 867% increase in Q1 2025 (shares fell 17% over the following quarter), a 29% increase in Q4 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 855 $703.63K New
Q4 2023 905 $794.85K Add
Q1 2024 905 $871.05K Hold
Q2 2024 905 $951.18K Hold
Q3 2024 905 $951.37K Hold
Q4 2024 875 $623.29K Reduce
Q1 2025 8.46K $5.37M Add
Q2 2025 8.50K $4.46M Hold
Q3 2025 8.26K $4.65M Reduce
Q4 2025 10.67K $8.24M Add
Q1 2026 10.89K $8.42M Add
Q2 2026 11.21K $6.99M Add
Q3 2026 10.98K $8.33M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Biondo Investment Advisors, LLC held REGN?

Biondo Investment Advisors, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Biondo Investment Advisors, LLC's current position in REGN?

As of Q3 2026, Biondo Investment Advisors, LLC holds 10.98K shares of REGN (REGENERON PHARMACEUTICALS), valued at $8.33M, representing 0.99% of its reported portfolio and ranking #34.

Has Biondo Investment Advisors, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Biondo Investment Advisors, LLC reduced its position in REGN. The position peaked in Q1 2026 at 10.89K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.